Company Directory > MedTech > HeartFlow, Inc.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of HeartFlow, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
HeartFlow, Inc. is a commercial-stage medical technology company that provides non-invasive solutions for diagnosing and managing coronary artery disease (CAD). The company utilizes artificial intelligence (AI) and computational fluid dynamics to create personalized 3D models of a patient's heart from coronary computed tomography angiography (CCTA) scans, offering insights into blood flow, stenosis, and plaque composition.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Digital Health / Cardiovascular Diagnostics
SIZE & FINANCIALS
Employees:501-1000
Revenue:$100M-$200M
Founded:2007
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$1.06B
Investors:Bain Capital Life Sciences, USVP
STOCK
Exchange:NASDAQ
Ticker:HTFL
Market Cap:$2.2B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Software/Medical Device)
Modalities:Digital Health, Artificial Intelligence, Medical Imaging
Active Trials:0
Trial Phases:-
FDA Approvals:2
EMA Approvals:1
CORPORATE STRUCTURE
Key Partnerships:Siemens Healthineers (Integration with scanners)
COMPETITION
Position:Leader
Competitors:Boston Scientific, Cardiovascular Systems, CathWorks, Medis
LEADERSHIP
Key Executives:
John Stevens - CEO / President
Charles Taylor - Founder, Chief Technology Officer
Lance Scott - Chief Commercial Officer
Scientific Founders:Charles Taylor
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with HeartFlow, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.